Richard A. Graham - 14 Jul 2023 Form 4 Insider Report for Theravance Biopharma, Inc. (TBPH)

Role
SVP, RESEARCH & DEVELOPMENT
Signature
/s/ Brett A. Grimaud, Attorney-in-Fact
Issuer symbol
TBPH
Transactions as of
14 Jul 2023
Net transactions value
-$22,848
Form type
4
Filing time
18 Jul 2023, 18:14:58 UTC
Previous filing
16 Jun 2023
Next filing
15 Aug 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TBPH Ordinary Shares Sale $22,848 -2,322 -0.66% $9.84 352,068 14 Jul 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in accordance with the reporting person's 10b5-1 plan dated 11/23/22.